Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
Multiple Ascending Dose of DW4421, phase I
Healthy adult aged 19 to 50 (inclusive) years, at the time of screening. [+1]
Those who have clinical significant liver, kidney, nervous system, respiratory,...
Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin
Healthy adult aged 19 to 50 (inclusive) years, at the time of screening. [+1]
Those who have clinical significant liver, kidney, nervous system, respiratory,...
Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1
Healthy adult aged 19 to 50 (inclusive) years [+1]
clinical significant liver, kidney, nervous system, respiratory, endocrine, hema...
This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.
Healthy adult volunteers aged 19 years or older at the time of screening [+1]
Those with a current or past medical history of clinically significant liver, ki...
Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs
Healthy adult aged 19 to 50 (inclusive) years, at the time of screening. [+1]
Those who have clinical significant liver, kidney, nervous system, respiratory,...
This study aims to compare the efficacy and safety of DW1807 and DW1807-R2 in patients with perennial allergic rhinitis and comorbid asthma. The primary objective is to demonstrate the superiority of DW1807 over DW1807-R2 in improving the reflective total nasal symptom score (rTNSS) after 4 weeks of treatment.
Male or female adults aged 19 years or older. [+6]
Individuals diagnosed with non-allergic rhinitis of other causes. [+10]